Yaqiang Cao

14PUBLICATIONS
49CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Gene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 19, 2026
Destabilization of intratumor Tregs by CTLA-4 engagement confers anti-CTLA-4-driven immunotherapy.

|Mar 27, 2026
Ryder: Epigenome normalization using a two-tier model and internal reference regions.

Yaqiang Cao, Guangzhe Ge, Keji Zhao

|Mar 19, 2026
Chromatin reorganization drives overexpression of a Btaf1 variant underpinning hematopoietic aging.

Le Zong, Bongsoo Park, Yaqiang Cao

|Jul 18, 2025
BLIMP1 negatively regulates IL-2 signaling in T cells.

Suyasha Roy, Min Ren, Peng Li

|Jun 21, 2024
Optimal CXCR5 Expression during Tfh Maturation Involves the Bhlhe40-Pou2af1 Axis.

Xiaoliang Zhu, Xi Chen, Yaqiang Cao

|Jun 12, 2024
Three-dimensional chromatin reorganization regulates B cell development during ageing.

Fei Ma, Yaqiang Cao, Hansen Du

Pageof 3

Frequent Collaborators

6 joint publications

Keji Zhao

3 joint publications

Fei Ma

2 joint publications

Xiang Qiu

2 joint publications

Isabel Beerman